• 2019 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2019 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    March 28-30, 2019, Chicago Hilton, Chicago, IL.

    Earn up to 11.5 CNE hours.

     

    Find out more about it and REGISTER today!

  • AwardCall for Excellence Award Nominations

    The awards are: Emerging Chapter Award, Established Chapter Excellence Award, Special Interest Group Excellence Award, Excellence in Clinical Practice Award, Excellence in Community Service Award, Excellence in Education Award, Excellence in Leadership Award, and Excellence in Research Award.

    The nominations are tallied in July and the winners are announced every year during the Awards Celebration at the GAPNA Annual Conference.

    Now is the time to nominate a colleague or yourself - DEADLINE is June 1, 2018.

    Get started... nominate today!

  • W A N T E D   G A P N A   L E A D E R S!
    Call for Nominations!

    Have you ever considered stepping forward, accepting the challenge and volunteering for a position on the 2019 National Board of Directors? Register online NOW by April 1, 2019!

    Step Up - NOW is the Time! Register Here>

  • FREE continuing education credit is available for the following session:

    "Keynote Address - Health Policy: APRNs Working to the Full Extent of the Law"

    (session captured at the GAPNA 2018 Annual Conference)


    For March/April 2019 - Get Your Free CNE Now!

  • Poster Presentation

       

    This 22-module curriculum provides a basic knowledge base for Nurse Practitioners who looking to advance their expertise in caring for patients with dementia.
     

    FREE to GAPNA members until September 1, 2019

  • GAPNA Exchange

       

    GAPNA Exchange is a private, secure community for members to share ideas, ask questions, lend expertise, and network with peers.

    It features both an Open Forum discussion area along with smaller, segmented communities.

    Interact with GAPNA members wherever and whenever!

    Go to GAPNA Exchange

Key Treatments for High Blood Pressure and High Blood Lipids Do Not Reduce Elderly Patients' Risk of Limited Mobility

Use of angiotensin-converting enzyme (ACE) inhibitors and statins do not reduce the risk of impaired mobility in older adults, a new study finds.

Impairments in mobility are common in older adults, with 15% of older men and 23% of older women unable to walk two to three blocks.

Chronic inflammation has been identified as a factor leading to a decline in functional status, including mobility. Both ACE inhibitors and statins may decrease systemic inflammation

In addition, ACE inhibitors may have a direct effect on muscle mass.

To see if these medications would indirectly have a positive impact on mobility, the researchers followed 3,055 healthy older adults, who had no mobility problems at baseline, for 6.5 years.

At baseline, the participants were in their 70s and had no difficulty walking a quarter-mile, climbing 10 steps, or performing basic activities of daily living; 15.2% used ACE inhibitors and 12.9% used statins. By year 6, ACE inhibitor use increased to 25.6% and statin use to 28.6%.

At the end of the 6.5-year study, 49.8% of the remaining adults had developed mobility limitation.

In separate multivariable models, neither ACE inhibitor use nor statin use was significantly associated with lower risk of mobility limitation.

For more info, see Gray et al. (2011). iAngiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: The Health, Aging and Body Composition Study. Journal of the American Geriatrics Society, 59(12), 2226-2232.

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: